Hermetica Superfood Encyclopedia
The Short Answer
Epimedin C is a prenylated flavonol glycoside derived from Epimedium species (horny goat weed) that exerts neuroprotective and anti-inflammatory effects primarily by activating the Nrf2/HO-1 antioxidant signaling pathway. It also inhibits NF-κB-mediated inflammatory cascades and shares structural similarity with icariin, the benchmark bioactive compound of Epimedium.
CategoryNamed Bioactive Compounds
GroupCompound
Evidence LevelModerate
Primary KeywordEpimedin C benefits
Synergy Pairings3
Epimedin C (flavonol glycoside) — botanical close-up
Health Benefits
Origin & History
Natural habitat
Epimedin C is a flavonol glycoside isolated from Epimedium species (horny goat weed), a traditional medicinal plant native to China and Southeast Asia. It is extracted from the aerial parts of the plant using standard solvent extraction and purification techniques.
“Epimedin C comes from Herba Epimedii (Epimedium), traditionally used in Chinese herbal medicine for treating diabetes and as an edible herb in China and Southeast Asia. The parent plant has historical use for stimulating bone growth, preventing bone loss, and treating neurodegeneration and osteoarthritis.”Traditional Medicine
Scientific Research
No human clinical trials have been conducted on Epimedin C. All available evidence comes from preclinical studies including PC12 cell models showing neuroprotection at 1-10 µM concentrations, chondrocyte studies demonstrating anti-inflammatory effects at 10-20 µM, and various animal models investigating diabetes and asthma.
Preparation & Dosage
Traditional preparation
No clinically studied human dosages are available. In vitro studies used 1-10 µM for neuroprotection and 10-20 µM for anti-inflammatory effects. No standardized extract forms or human dosing guidelines exist. Consult a healthcare provider before starting any new supplement.
Nutritional Profile
Epimedin C is a purified flavonol glycoside compound (prenylflavonoid), not a whole food ingredient, and therefore has no conventional macronutrient or micronutrient profile. Structural composition: molecular formula C38H48O20, molecular weight approximately 820.77 g/mol. It is a prenylated flavonol glycoside consisting of a kaempferol aglycone core with a prenyl (3,3-dimethylallyl) substituent at C-8 and a trisaccharide chain (rhamnose-rhamnose-glucose) at C-3, which classifies it as an icariin-type flavonoid. Naturally sourced from Epimedium species (Yin Yang Huo/Horny Goat Weed) where it co-occurs with related compounds icariin, epimedin A, and epimedin B; typical concentration in Epimedium plant material ranges from 0.1–2.5% dry weight depending on species and plant part. As an isolated compound, it contains no fiber, protein, fat, or micronutrients. Bioavailability is a key limitation: oral bioavailability is low due to poor aqueous solubility (lipophilic prenyl group) and extensive first-pass metabolism; gut microbiota hydrolyze the glycoside to release the aglycone icaritin, which is considered the primary bioactive form. Plasma half-life and peak concentration data remain limited to preliminary pharmacokinetic studies in rodent models. No established dietary reference intake or tolerable upper limit exists.
How It Works
Mechanism of Action
Epimedin C activates the Nrf2/HO-1 (nuclear factor erythroid 2-related factor 2 / heme oxygenase-1) pathway, upregulating antioxidant response elements and reducing reactive oxygen species-mediated apoptosis in neuronal cells. It concurrently suppresses NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) nuclear translocation, thereby reducing downstream pro-inflammatory cytokine production including IL-1β, IL-6, and TNF-α. In chondrocyte models, it inhibits MMP-3 and MMP-13 matrix metalloproteinase expression, potentially protecting cartilage extracellular matrix from degradation.
Clinical Evidence
Current evidence for Epimedin C is limited to in vitro cell culture studies and animal models, with no completed human clinical trials specifically isolating this compound. PC12 neuronal cell studies demonstrated reduced hydrogen peroxide-induced apoptosis and increased cell viability through Nrf2/HO-1 activation, though these findings have not been translated to human subjects. In vitro chondrocyte studies showed dose-dependent reductions in IL-1β-stimulated inflammatory markers, suggesting potential osteoarthritis relevance. The overall evidence base is preliminary, and extrapolating these findings to human supplementation requires significant caution until randomized controlled trials are conducted.
Safety & Interactions
No human safety or tolerability trials have been conducted specifically for isolated Epimedin C, making definitive risk profiling impossible at this time. As a constituent of Epimedium extracts, it may share the class-level concern of potential estrogenic activity, warranting caution in individuals with hormone-sensitive conditions such as estrogen receptor-positive cancers. Epimedium-based products have been associated with rare reports of hepatotoxicity and tachyarrhythmia, though causality for individual glycosides like Epimedin C has not been established. Pregnant or breastfeeding individuals and those taking anticoagulants, hormonal therapies, or cytochrome P450-metabolized drugs should avoid use pending further safety data.
Synergy Stack
Hermetica Formulation Heuristic
Frequently Asked Questions
What is Epimedin C and how does it differ from icariin?
Epimedin C is a prenylated flavonol glycoside found in Epimedium brevicornum and related species, differing from icariin in its glycosylation pattern — Epimedin C carries two sugar moieties (rhamnose and glucose) compared to icariin's single glycoside structure. Both compounds share the core flavonol prenyl scaffold and inhibit PDE5 and NF-κB pathways, but Epimedin C shows comparatively stronger Nrf2 activation in neuronal models. Icariin remains more extensively studied in humans, while Epimedin C research is confined to preclinical settings.
Can Epimedin C help with osteoarthritis?
Preclinical in vitro studies using IL-1β-stimulated human chondrocytes showed that Epimedin C reduced expression of MMP-3, MMP-13, and pro-inflammatory cytokines IL-6 and TNF-α in a dose-dependent manner. These findings suggest a potential cartilage-protective mechanism via NF-κB pathway suppression. However, no animal arthritis models or human clinical trials have been published specifically for Epimedin C, so its clinical utility in osteoarthritis remains unproven.
Does Epimedin C protect against neurodegeneration?
In PC12 rat pheochromocytoma cell studies, Epimedin C reduced hydrogen peroxide-induced cytotoxicity and caspase-3-mediated apoptosis by upregulating Nrf2, HO-1, and NQO1 antioxidant proteins. These results indicate a plausible neuroprotective mechanism relevant to oxidative stress-driven conditions like Parkinson's or Alzheimer's disease. Nonetheless, no human neurological trials exist, and the jump from cell line data to clinical neuroprotection is substantial and speculative at this stage.
What is the typical dosage of Epimedin C in supplements?
No clinically validated dosage has been established for isolated Epimedin C because human pharmacokinetic and dose-finding trials have not been conducted. In standardized Epimedium extracts, Epimedin C is typically present alongside icariin, epimedin A, and epimedin B, with the total flavonoid content often standardized to 10–40% by weight. Anyone considering Epimedium-based supplements should follow manufacturer guidelines and consult a healthcare provider, as effective and safe doses for Epimedin C specifically remain undefined.
Are there any known drug interactions with Epimedin C?
No direct drug interaction studies have been performed on isolated Epimedin C. Based on its structural class and Epimedium source, theoretical interactions include potentiation of anticoagulants such as warfarin through platelet aggregation inhibition, and possible interference with hormonal therapies due to weak estrogenic activity at estrogen receptor alpha. Epimedium constituents are also metabolized via CYP3A4 pathways, suggesting potential interactions with drugs sharing this metabolic route, including certain statins, immunosuppressants, and HIV protease inhibitors.
What is the bioavailability of Epimedin C, and does it absorb better with food or on an empty stomach?
Epimedin C is a flavonol glycoside with moderate bioavailability that may be enhanced when consumed with dietary fats, which can improve absorption of lipophilic compounds. As a glycoside, it may undergo some hydrolysis in the digestive tract to release the aglycone form, which can improve cellular uptake. Current research has not definitively established whether food significantly impacts Epimedin C absorption compared to fasting conditions, so taking it consistently with or without meals is reasonable until more specific data emerges.
Is Epimedin C safe for pregnant women or breastfeeding mothers?
Safety data for Epimedin C during pregnancy and lactation is limited, and most supplement manufacturers recommend avoiding supplementation in these populations without medical supervision. The compound's estrogenic properties (related to its structural similarity to icariin) raise theoretical concerns during pregnancy, though human studies are absent. Women who are pregnant or breastfeeding should consult a healthcare provider before using Epimedin C supplements.
What does the current clinical research show about Epimedin C's effectiveness compared to preclinical evidence?
Most evidence for Epimedin C comes from in vitro cell studies and animal models, which demonstrate neuroprotective and anti-inflammatory effects through pathways like Nrf2/HO-1 activation. Human clinical trials specifically testing Epimedin C are limited, making it difficult to confirm that laboratory findings translate to real-world supplementation benefits. Until robust randomized controlled trials in humans are published, Epimedin C should be considered a promising but not yet clinically proven ingredient.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w epimedin-c curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
